| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing precisely prednisolone 2.5 milligram/1 each gastro-resistant oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone 2.5 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone 5 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone 5 milligram/1 each gastro-resistant oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone (as prednisolone sodium phosphate) 5 mg rectal suppository |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone 50 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone 25 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone 1 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone 3 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone 3 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone 2 milligram/1 milliliter conventional release oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone 2 milligram/1 milliliter conventional release oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone 1 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone 1 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone 3 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone 3 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing neomycin and polymyxin B and prednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Cinchocaine and prednisolone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Neomycin and polymyxin B and prednisolone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only neomycin and prednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only gentamicin and prednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only prednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone only product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone (as prednisolone sodium phosphate) 5 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone (as prednisolone sodium phosphate) 10 milligram/1 each conventional release orodispersible tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone (as prednisolone sodium phosphate) 15 mg orodispersible tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone (as prednisolone sodium phosphate) 1 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone (as prednisolone sodium phosphate) 30 mg orodispersible tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone 25 milligram/1 milliliter conventional release eye suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone 25 milligram/1 milliliter conventional release eye suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone (as prednisolone sodium phosphate) 5 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone 1.25 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone 1.25 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone (as prednisolone sodium phosphate) 10 microgram/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone (as prednisolone sodium phosphate) 30 microgram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone 5 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone 5 milligram/1 each conventional release orodispersible tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing prednisolone in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only cinchocaine and prednisolone in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing prednisolone in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Neomycin- and prednisolone-containing product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Neomycin- and prednisolone-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only neomycin and prednisolone in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Neomycin and prednisolone only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone- and sulfacetamide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only prednisolone and sulfacetamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone- and sulfacetamide-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone and sulfacetamide only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Cinchocaine- and prednisolone-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only prednisolone in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone metasulfobenzoate sodium (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
|
| Prednisolone (as prednisolone metasulfobenzoate sodium) 20 mg/actuation rectal foam |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone (as prednisolone sodium phosphate) 5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Prednisolone (as prednisolone sodium phosphate) 2 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone (as prednisolone sodium phosphate) 5 milligram/1 each conventional release orodispersible tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone (as prednisolone acetate) 5 milligram/1 gram conventional release oromucosal paste (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
| Serum prednisolone level (procedure) |
Component |
True |
Prednisolone (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]